FAQs About AcuamarkDx

Does Early Detection of Cancer from a Blood Sample Help Increase Survival and Cure Rates?

Precise early detection of cancer can significantly improve cure and survival rates. It identifies the growth before cancer cells become more aggressive and the tumor mass grows, spreads uncontrollably or metastasizes throughout the body.

The ability to detect molecular markers in the blood provides hope that cancers could be eradicated earlier. For instance, for colorectal cancer, early cancer survival rates are higher than 90% (stage 1), but when discovered too late (stage 4), survival rates plummet to less than 10%. Currently, over 60% of cancers are detected at stage 3 or later, and in the aggregate, the average survival of cancer patients is 50%. With reliable and accessible stage 1 and 2 cancer detection, average cancer survival rates could be increased to 70-90%.

In an ideal scenario, widespread adoption of a precise and affordable screening test by the medical community and the public could significantly decrease cancer-related deaths, by between 35% and 55%. This, in turn, could result in a corresponding reduction in the economic and healthcare costs associated with cancer, potentially lowering expenses by 50% to 75%.

AcuamarkDx logo

Acuamark Diagnostics develops technology that allows for highly accurate screening of blood to detect cancer markers at the early cancer stages, before cancer becomes untreatable.

Contact Us